We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
-11.11%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$40.6M
Cap. Flow
-$94.7M
Cap. Flow %
-83.37%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$29.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 26.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIOR
1
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$23.7M 20.89%
1,092,976
+923,528
+545% +$29.6M
PBYI icon
2
Puma Biotechnology
PBYI
$405M
$4.71M 4.15%
1,792,114
– –
RVLP
3
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.26M 1.11%
14,600,444
– –

Similar funds

BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return

Athyrium Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Athyrium Capital Management held 6 positions worth $114M, down 26% from $154M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Athyrium Capital Management withdrew a net $94.7M in Q3 2023.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 14% a quarter earlier.

Against the trend, Athyrium Capital Management added an estimated $29.6M to Biora Therapeutics, Inc. Common Stock.

  • Athyrium Capital Management added most to Biora Therapeutics, Inc. Common Stock in Q3 2023, an estimated $29.6M increase.
  • Athyrium Capital Management's ten largest holdings make up 100% of its $114M portfolio in Q3 2023.
  • Athyrium Capital Management opened 0 new positions and closed 0 in Q3 2023.
  • Athyrium Capital Management's portfolio value fell 26% quarter-over-quarter to $114M.

Based on Athyrium Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.